Profile
BCLI VRTX REGN VRNA ARGX ALNY
Company Name Brainstorm Cell Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.18M $116.75B $76.56B $72.68B $52.08B $51.68B
Employees 0.03K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Chaim Lebovits Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
BCLI VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
BCLI VRTX REGN VRNA ARGX ALNY
Last Close $0.68 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $2.48 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.55 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -72.58 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 23.64 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
BCLI VRTX REGN VRNA ARGX ALNY
1 Month Return 4.62 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 11.48 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -48.48 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -63.04 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -70.04 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -45.6 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BCLI VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
BCLI VRTX REGN VRNA ARGX ALNY
Asset Growth -56.46 % 14.15 % 53.91 %
Gross Profit Growth 420.38 % 12.5 % -
Revenue Growth - 8.27 % -
Revenue 3 Year - -13.44 % -15.89 %
Revenue 5 Year 174.48 % 119.18 % -
Revenue 10 Year - 429.43 % -
EBIT Growth 32.84 % 13.17 % -131.37 %
Net Income Growth 167.61 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share 121.7 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share 116.05 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share 126.35 % 1232.49 % -35.51 %
Operating Income Growth 45.46 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) 55.55 % -3.78 % -143.33 %
Operating 3 Year CFG 84.19 % -38.85 % -170.73 %
Operating 5 Year CFG 74.04 % 84.11 % 54.81 %
Operating 10 Year CFG 57.51 % 517.51 % 40.15 %
EPS Growth 148.88 % 10.39 % -214.81 %
EPS Diluted Growth 148.88 % 10.27 % -208.93 %
Book Value Per Share -15.55 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -118.33 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share 79.6 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share -124.38 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -43.53 % 0.06 % 139.05 %
Free Cash Flow Growth 55.59 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
BCLI VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 68.43 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -1243.81 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 212.08 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 133.7 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 99.52 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -1283.63 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -2234.05 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 10.61 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 0.01 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 137.6 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 97.36 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.66 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.66 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 0.05 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -857.83 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -2234.05 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.85 34.99 18.43 -995.27 133.11 233.46
Price To Operating Cash Flows Ratio TTM -0.85 31.28 15.15 -126.33 152.03 193.4
Price Cash Flow Ratio TTM -0.85 31.28 15.15 -126.33 152.03 193.4
Income Statement (TTM)
BCLI VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $0.01B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted 2.19 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
BCLI VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.01B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $-0.01B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
BCLI VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 28.72
AARD Aardvark Therapeutics, Inc. Common Stock 13.575
ABCL AbCellera Biologics Inc. 3.465
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.92
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.105
ABPWW 0.014
ABSI Absci Corporation 3.55
ABUS Arbutus Biopharma Corporation 4.58
ABVC ABVC BioPharma, Inc. 2.045
ABVX Abivax SA American Depositary Shares 110.73
ACAD ACADIA Pharmaceuticals Inc. 27.177
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4812
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.33
ACIU AC Immune SA 3.0932
ETFs With Exposure to BCLI
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 332.225
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00006 146.89
VXF Vanguard Extended Market Index Fund 0.00003 210.678
IWC iShares Micro-Cap ETF 0.00458 159.595
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.75
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.73
STSB iShares Factors US Small Blend Style ETF 0.02 21.66
VTSAX Vanguard Total Stock Market Index Fund 0 162.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00003 160.26
VITSX Vanguard Total Stock Market Index Fund 0 162.82
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000106985 16.3
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00003 160.27
AVSC Avantis U.S. Small Cap Equity ETF 0 59.605
VEMPX Vanguard Extended Market Index InstlPlus 0.00003 395.49
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 305.43
Unlock